SOTAGLIFLOZIN for Cardiomyopathy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where SOTAGLIFLOZIN was used for Cardiomyopathy.
Most Reported Side Effects for SOTAGLIFLOZIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Dizziness | 51 | 10.8% | 0 | 3 |
| Diarrhoea | 45 | 9.5% | 0 | 1 |
| Therapy interrupted | 28 | 5.9% | 0 | 6 |
| Death | 24 | 5.1% | 24 | 0 |
| Off label use | 24 | 5.1% | 0 | 1 |
| Dyspnoea | 22 | 4.7% | 0 | 2 |
| Headache | 21 | 4.5% | 0 | 0 |
| Urinary tract infection | 21 | 4.5% | 0 | 6 |
| Product use issue | 20 | 4.2% | 0 | 5 |
| Nausea | 18 | 3.8% | 0 | 0 |
| Fungal infection | 16 | 3.4% | 0 | 2 |
| Fatigue | 14 | 3.0% | 0 | 1 |
| Vomiting | 14 | 3.0% | 0 | 0 |
| Drug ineffective | 13 | 2.8% | 0 | 1 |
| Hospitalisation | 12 | 2.5% | 0 | 12 |
Other Indications for SOTAGLIFLOZIN
Product used for unknown indication (292)
Cardiac failure (31)
Chronic left ventricular failure (31)
Cardiac failure congestive (29)
Type 2 diabetes mellitus (17)
Cardiac disorder (11)
Left ventricular failure (8)
Other Drugs Used for Cardiomyopathy
SACUBITRIL\VALSARTAN (527)
FUROSEMIDE (255)
TAFAMIDIS (163)
SPIRONOLACTONE (121)
BISOPROLOL (114)
TAFAMIDIS MEGLUMINE (102)
AMIODARONE (92)
CARVEDILOL (88)
METOPROLOL (87)
LISINOPRIL (59)